High cathepsin B expression in lung, ovarian, pancreatic neuroendocrine cancers and pancreatic adenocarcinomas, is negatively correlated with survival and positively associated with recurrence, invasion, and/or tumor grade. This evidence concerns the gene CTSB and pancreatic endocrine carcinoma.